semaglutide hepatic impairment pharmacokinetics A phase 1, randomized, double‐blind, placebo‐controlled trial investigating the pharmacokinetics, pharmacodynamics, safety and tolerability of oral in healthy Chinese subjects - Xie - 2024 - Diabetes, Obesity and Metabolism semaglutide hepatic impairment pharmacokinetics Browse
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20























